Q2 2024 |
2 |
$25.7M |
$0 |
-$11 |
-$11 |
INSG
|
13F-HR |
8/14/2024, 12:18 PM |
Q1 2024 |
2 |
$13.2M |
$0 |
-$32.8M |
-$32.8M |
INSGXXXX
|
13F-HR |
5/15/2024, 11:32 AM |
Q4 2023 |
2 |
$13M |
$0 |
-$139M |
-$139M |
INSGXXXX
|
13F-HR |
2/14/2024, 04:08 PM |
Q3 2023 |
4 |
$156M |
$0 |
$0 |
|
MRTX, INSGXXXX, TNGX
|
13F-HR |
11/14/2023, 04:44 PM |
Q2 2023 |
4 |
$137M |
$0 |
$0 |
|
MRTX, INSGXXXX, TNGX
|
13F-HR |
8/14/2023, 04:18 PM |
Q1 2023 |
4 |
$143M |
$0 |
$0 |
|
MRTX, INSGXXXX, TNGX
|
13F-HR |
5/15/2023, 04:08 PM |
Q4 2022 |
4 |
$174M |
$0 |
-$10.7M |
-$10.7M |
MRTX, INSGXXXX, TNGX
|
13F-HR |
2/14/2023, 04:23 PM |
Q3 2022 |
5 |
$277M |
$0 |
-$16.6M |
-$16.6M |
MRTX, INSGXXXX, PAM, TNGX
|
13F-HR |
11/14/2022, 04:17 PM |
Q2 2022 |
5 |
$278M |
$0 |
-$1.14M |
-$1.14M |
MRTX, INSGXXXX, PAM, TNGX
|
13F-HR |
8/15/2022, 04:36 PM |
Q1 2022 |
5 |
$379M |
+$4.32M |
$0 |
+$4.32M |
MRTX, INSGXXXX, PAM, TNGX
|
13F-HR |
5/16/2022, 04:15 PM |
Q4 2021 |
5 |
$615M |
+$18.7M |
$0 |
+$18.7M |
MRTX, INSGXXXX, PAM, TNGX
|
13F-HR |
2/14/2022, 04:05 PM |
Q3 2021 |
5 |
$709M |
+$7.46M |
$0 |
+$7.46M |
MRTX, INSGXXXX, PAM, TNGX
|
13F-HR |
11/15/2021, 04:31 PM |
Q2 2021 |
3 |
$724M |
$0 |
$0 |
|
MRTX, INSGXXXX
|
13F-HR |
8/16/2021, 04:16 PM |
Q1 2021 |
3 |
$752M |
$0 |
$0 |
|
MRTX, INSGXXXX
|
13F-HR |
5/17/2021, 04:15 PM |
Q4 2020 |
3 |
$1.02B |
$0 |
-$36.9M |
-$36.9M |
MRTX, INSGXXXX
|
13F-HR |
2/16/2021, 04:11 PM |
Q3 2020 |
3 |
$767M |
$0 |
-$7.35M |
-$7.35M |
MRTX, INSGXXXX
|
Restatement |
11/17/2020, 12:35 PM |
Q2 2020 |
5 |
$643M |
+$22.5M |
-$50.6M |
-$28.1M |
MRTX, INSGXXXX, PAM, SLDB
|
13F-HR |
8/14/2020, 04:26 PM |
Q1 2020 |
5 |
$439M |
+$21.1M |
$0 |
+$21.1M |
MRTX, INSG, PAM, SLDB
|
13F-HR |
5/15/2020, 04:16 PM |
Q4 2019 |
5 |
$613M |
+$9.8M |
-$41.2M |
-$31.4M |
MRTX, INSG, PAM, SLDB
|
13F-HR |
2/14/2020, 04:12 PM |
Q3 2019 |
1 |
$55.4M |
$0 |
$0 |
|
PAM
|
New Holdings |
2/14/2020, 04:19 PM |
Q3 2019 |
6 |
$425M |
+$55.4M |
-$43.4M |
+$12M |
MRTX, INSG, PAM, MDCO, SLDB
|
13F-HR |
11/14/2019, 04:41 PM |
Q2 2019 |
5 |
$478M |
+$15.2M |
-$120M |
-$105M |
MRTX, INSG, MDCO, SLDB
|
Restatement |
8/28/2019, 04:30 PM |
Q1 2019 |
6 |
$456M |
$0 |
-$971K |
-$971K |
MRTX, MDCO, INSG, ESPR, SLDB
|
13F-HR |
5/15/2019, 04:35 PM |
Q4 2018 |
7 |
$317M |
+$40.5M |
-$42.1M |
-$1.67M |
MRTX, INSG, MDCO, ESPR, SLDB
|
13F-HR |
2/14/2019, 04:22 PM |
Q3 2018 |
7 |
$375M |
+$34.8M |
-$6.7M |
+$28.1M |
MRTX, MDCO, ESPR, INSG, MGNX
|
13F-HR |
11/14/2018, 04:17 PM |
Q2 2018 |
6 |
$616M |
+$311M |
-$2.36M |
+$308M |
MRTX, MDCO, ESPR, MGNX, SLDB
|
13F-HR |
8/14/2018, 04:17 PM |
Q1 2018 |
5 |
$246M |
+$17M |
$0 |
+$17M |
MDCO, MRTX, MGNX, ESPR, PTCT
|
13F-HR |
5/15/2018, 04:15 PM |
Q4 2017 |
5 |
$156M |
$0 |
$0 |
|
MDCO, MRTX, MGNX
|
13F-HR |
2/14/2018, 04:54 PM |
Q3 2017 |
4 |
$192M |
+$192M |
$0 |
+$192M |
MDCO, MRTX, ESPR, MGNX
|
13F-HR |
11/14/2017, 04:25 PM |
Q2 2017 |
3 |
$13K |
$0 |
$0 |
|
ESPR, MDCO, MRTX
|
New Holdings |
2/14/2018, 04:08 PM |
Q2 2017 |
3 |
$13K |
$0 |
$0 |
|
ESPR, MDCO, MRTX
|
13F-HR |
8/14/2017, 04:40 PM |
Q1 2017 |
3 |
$14K |
$0 |
$0 |
|
MDCO, MRTX, ESPR
|
New Holdings |
2/14/2018, 04:27 PM |
Q1 2017 |
3 |
$14K |
+$9K |
-$9.96M |
-$9.95M |
MDCO, MRTX, ESPR
|
13F-HR |
5/15/2017, 04:48 PM |
Q4 2016 |
2 |
$9.46M |
$0 |
$0 |
|
MRTX
|
13F-HR |
2/14/2017, 05:07 PM |
Q3 2016 |
1 |
$13.2M |
$0 |
-$116M |
-$116M |
MRTX
|
13F-HR |
11/14/2016, 04:51 PM |
Q2 2016 |
2 |
$127M |
+$10.3M |
-$37.2M |
-$26.9M |
NTL, MRTX
|
13F-HR |
8/15/2016, 04:46 PM |
Q1 2016 |
3 |
$143M |
+$41M |
$0 |
+$41M |
NTL, PAM, MRTX
|
13F-HR |
5/16/2016, 04:30 PM |
Q4 2015 |
3 |
$91.2M |
$0 |
$0 |
|
NTL, PAM, MRTX
|
13F-HR |
2/16/2016, 04:31 PM |